Anti-CD123 monoclonal antibody (talacotuzumab biosimilar)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMA1003-100uL

  • Size

    100uL

  • Price

    $320

1
Talacotuzumab (also known as JNJ-56022473 or CSL-362) is a humanized IgG1 monoclonal antibody. It targets to CD123 (Interleukin-3 receptor alpha chain or IL3RA). It is being developed by Johnson & Johnson in collaboration with GSK, for treatment of AML (acute myeloid leukemia).
target IL3RA
gene id 3563
alias CD123, IL3R, IL3RA
reactivity Human
host Humanized
clonality Monoclonal
clone number CSL-362-AML, CSL362, JNJ-56022473
iso type IgG1
formulation Purified from cell culture supernatant by affinity chromatography; Kept in PBS (pH 7.4) with 0.1% BSA, 0.1% ProClin 300 and 50% Glycerol
applications ELISA, Flow Cytometry
dilution ELISA 1:5000-10000
shipping With ice packs
storage Store at -20°C for at least 1 year. Avoid multiple freeze-thaw cycles.

PRODUCT

  • SKU

    DMA1003-100uL

  • Size

    100uL

  • Price

    $320

1